Lanzhou Bathcon Pharmaceutical Co., Ltd. specializes in the R&D and manufacturing of APIs, pharmaceutical intermediates and finished dosage forms. Established in 2005, the group operates three manufacturing bases dedicated to producing APIs and intermediates, lyophilized powder for injection, tablets, powder injections and granules, with an annual production capacity exceeding 300 metric tons of APIs, 360 metric tons of intermediates and 10 million vials of sterile lyophilized powder, operating under four core management systems covering quality, EHS, intellectual property and pharmaceutical management to ensure product quality.

Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen